课题基金 / 基金详情

Enhancement of the anti-tumour efficacy of ionising radiation through inhibition of phosphoinositide 3-kinase

Enhancement of the anti-tumour efficacy of ionising radiation through inhibition of phosphoinositide 3-kinase
通过抑制磷酸肌醇3-激酶增强电离辐射的抗肿瘤功效
批准号:
nhmrc : 550301
负责人:
A/Pr Arun Azad
金额:
$8.24万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Postgraduate Scholarships
财政年份:
2009
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2009-01-01 至 2012-12-31

项目摘要

项目成果

A/Pr Arun Azad的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Radiation treatment alone is given to many cancer patients, however often it does not prevent cancers from recurring. Significant promise is offered by new drugs that target molecules which play a key role in cancer growth, and combining these drugs with radiation treatment may lead to improved patient outcomes. Understanding how these drugs enhance the anti-cancer effects of radiation is critical to selecting the most appropriate patients for treatment with this combination.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel targeting of therapy-resistant prostate cancer cells.
  • 批准号:
    nhmrc : 1140222
  • 项目类别:
    Project Grants
  • 资助金额:
    $40.36万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Arun Azad
  • 依托单位:
A novel strategy for targeting castrate-resistant prostate cancer
  • 批准号:
    nhmrc : 1138242
  • 项目类别:
    Project Grants
  • 资助金额:
    $54.05万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Arun Azad
  • 依托单位:
Novel targeting of therapy-resistant prostate cancer cells.
  • 批准号:
    nhmrc : GNT1140222
  • 项目类别:
    Project Grants
  • 资助金额:
    $59.7万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Arun Azad
  • 依托单位:
A novel strategy for targeting castrate-resistant prostate cancer
  • 批准号:
    nhmrc : GNT1138242
  • 项目类别:
    Project Grants
  • 资助金额:
    $79.94万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Arun Azad
  • 依托单位:
国内基金
海外基金
基于spA-Gel负载Anti-HMGB1原位靶向免疫耐受的猪胰岛类器官移植研
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    程瑶
  • 依托单位:
TKIs氘代化修饰通过促进HCC铁死亡增强免疫原性并增敏anti-PD-1治疗的机制研究
  • 批准号:
    JCZRQN202500319
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
肺癌外周血淋巴细胞亚群预测anti-PD1/PDL1疗效的鉴定及应用研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    仇凤启
  • 依托单位:
构建α-突触核蛋白特异性CAR-Treg治疗抗NMDAR脑炎的研究